Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Atherosclerosis

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2015.06.055PMID 26184694PMCID PMC4850906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors

  2013cited by this paper
• Association of chronic kidney disease with adverse outcomes - Authors' reply.

  2013cited by this paper
• Regulation of Peroxisome Proliferator–Activated Receptor-&ggr; by Angiotensin II Via Transforming Growth Factor-&bgr;1–Activated p38 Mitogen-Activated Protein Kinase in Aortic Smooth Muscle Cells

  2012influential reference
• Association of chronic kidney disease and coronary artery disease in 1,010 consecutive patients undergoing coronary angiography.

  2012cited by this paper
• Changes in albuminuria predict mortality and morbidity in patients with vascular disease.

  2011cited by this paper
• Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.

  2011cited by this paper
• HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells

  2011cited by this paper
• Pioglitazone for diabetes prevention in impaired glucose tolerance.

  2011cited by this paper
• Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis

  2011cited by this paper
• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  2011cited by this paper
• Autoimmune Kidney Disease and Impaired Engulfment of Apoptotic Cells in Mice with Macrophage Peroxisome Proliferator-Activated Receptor γ or Retinoid X Receptor α Deficiency

  2011cited by this paper
• Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

  2011cited by this paper
• Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.

  2011cited by this paper
• The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

  2011cited by this paper
• Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruct

  2011cited by this paper
• Gastrointestinal , Hepatobiliary and Pancreatic Pathology Essential Role for Macrophage Migration Inhibitory Factor in Gastritis Induced by Helicobacter pylori

  2010cited by this paper
• Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell–Specific Interaction With PPAR&ggr;

  2010cited by this paper
• Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell–Specific Interaction With PPARγ

  2010cited by this paper
• Macrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation

  2010cited by this paper
• Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease

  2009cited by this paper
• Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

  2009cited by this paper
• Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori.

  2009cited by this paper
• Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone.

  2009cited by this paper
• Mechanisms for increased cardiovascular disease in chronic kidney dysfunction

  2009cited by this paper
• Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice.

  2009cited by this paper
• Fetuin-A protects against atherosclerotic calcification in CKD.

  2009cited by this paper
• Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1

  2009cited by this paper
• Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice.

  2009cited by this paper
• Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients

  2008cited by this paper
• Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus

  2008cited by this paper
• Latent TGF-beta1 protects against crescentic glomerulonephritis.

  2008cited by this paper
• Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis.

  2008cited by this paper
• Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).

  2008cited by this paper
• Bcr Kinase Activation by Angiotensin II Inhibits Peroxisome Proliferator-Activated Receptor &ggr; Transcriptional Activity in Vascular Smooth Muscle Cells

  2008cited by this paper
• Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice.

  2007cited by this paper
• Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.

  2007cited by this paper
• Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases

  2006cited by this paper
• Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance.

  2006cited by this paper
• Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.

  2006cited by this paper
• Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.

  2006cited by this paper
• Conditional Knockout of Macrophage PPARγ Increases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor–Deficient Mice

  2005cited by this paper
• Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

  2005cited by this paper
• A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development.

  2005cited by this paper
• Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor–Null Mice

  2004cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.

  2004cited by this paper
• Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.

  2003cited by this paper
• Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death.

  2002cited by this paper
• Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

  2001cited by this paper
• Biochemical Characterization of Endogenously Formed Eosinophilic Crystals in the Lungs of Mice*

  2000cited by this paper
• Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.

  1992cited by this paper

• PPARγ activation reduces pancreatic beta cell death in type 1 diabetes by decreasing heparanase-dependent insulitis.

  2025cites this paper
• Immune-mediated interactions between sarcopenia and atherosclerosis in aging

  2025cites this paper
• Potassium Sorbate Triggers Kidney Injury via Dysregulated Intercellular Communication: A Study Combining Network Toxicology, Machine Learning, Molecular Docking, and Single‐Cell RNA Sequencing

  2025cites this paper
• Alpha-lipoic acid attenuates cardiac inflammation of CVB3 induced viral myocarditis via neutrophil-derived YM-1.

  2025cites this paper
• Macrophagic Ym1 orchestrates γδT cell-derived IL-17 production and keratinocyte functionality to mediate psoriasis-like skin inflammation

  2025cites this paper
• Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitization

  2024cites this paper
• Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model

  2024cites this paper
• Single-cell profile reveals the landscape of cardiac immunity and identifies a cardio-protective Ym-1hi neutrophil in myocardial ischemia-reperfusion injury.

  2024cites this paper
• Macrophage fatty acid oxidation in atherosclerosis.

  2023cites this paper
• Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells.

  2023cites this paper
• Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

  2022cites this paper
• The Biological Parallels Between Atherosclerosis and Cardiac Allograft Vasculopathy: Implications for Solid Organ Chronic Rejection

  2022cites this paper
• Ultrasonography Combined with Blood Biochemistry on the Early Diagnosis of Diabetic Kidney Disease

  2022cites this paper
• Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins.

  2021cites this paper
• Losartan protects against osteoarthritis by repressing the TGF-β1 signaling pathway via upregulation of PPARγ

  2021cites this paper
• A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease

  2021cites this paper
• Nuclear Receptors and Transcription Factors in Obesity-Related Kidney Disease.

  2021cites this paper
• Rice Endosperm Protein Improves the Anti-Inflammatory Effects of High-Density Lipoprotein and Produces Lower Atherosclerotic Lesion Accelerated by the Renal Mass Reduction than Casein in a Mouse Model.

  2021cites this paper
• The emerging role of COX-2, 15-LOX, and PPARγ in metabolic diseases and cancer: An introduction to novel multi-target directed ligands (MTDLs).

  2020cites this paper
• Unstable Carotid Plaque as a Phenotype of Chronic Systemic Inflammation Enhances Renal Insufficiency.

  2020cites this paper
• Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis.

  2020cites this paper
• M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment

  2019cites this paper
• Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis.

  2019cites this paper
• Losartan treatment attenuates the development of neuropathic thermal hyperalgesia induced by peripheral nerve injury in rats

  2019cites this paper
• Atherosclerosis in Chronic Kidney Disease.

  2019cites this paper
• Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis—Oshima Award Address 2016

  2018cites this paper
• Assessment of the Relationship between Carotid Intima-Media Thickening and Early-Stage Diabetic Kidney Disease Coupled with Helicobacter pylori Infection

  2018cites this paper
• Cucumis sativus Aqueous Fraction Inhibits Angiotensin II-Induced Inflammation and Oxidative Stress In Vitro

  2018cites this paper
• Probiotics ameliorate renal ischemia-reperfusion injury by modulating the phenotype of macrophages through the IL-10/GSK-3β/PTEN signaling pathway

  2018cites this paper
• 10,12 Conjugated Linoleic Acid-Driven Weight Loss Is Protective against Atherosclerosis in Mice and Is Associated with Alternative Macrophage Enrichment in Perivascular Adipose Tissue

  2018cites this paper
• The role of Wnt signaling pathway in atherosclerosis and its relationship with angiogenesis

  2018cites this paper
• Pioglitazone attenuates aging‐related disorders in aged apolipoprotein E deficient mice

  2018cites this paper
• Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated

  2018cites this paper
• Extracellular vesicles as mediators of vascular inflammation in kidney disease.

  2016cites this paper
• Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.

  2016cites this paper
• Pioglitazone alleviates inflammation in diabetic mice fed a high‐fat diet via inhibiting advanced glycation end‐product‐induced classical macrophage activation

  2016cites this paper
• PPARγ and the Innate Immune System Mediate the Resolution of Inflammation

  2015cites this paper